baber/WOPTO huggingface dataset:
Patent EP-2242357-A2 (EP)
Title: Nouveau materiau a proprietes bacteriostatiques
Inventor: BENOIT ROLAND
IPC: C08J9/00
Filed: 2009-02-03
Abstract: Procédé de fabrication d'un matériau composite comprenant une matrice polymérique poreuse à base de monomères HEMA, dans laquelle sont dispersées des nanoparticules d'argent, ses utilisations comme matériau antimicrobien.
Patent EP-2300137-A2 (EP)
Title: Procede et dispositf de lecture d'une emulsion
Inventor: BAUDRY JEAN
IPC: G01N21/64
Filed: 2009-07-13
Abstract: La présente invention concerne un procédé de lecture d'une émulsion (3) comprenant des gouttes et une phase continue entourant les gouttes, ledit procédé comprenant : un balayage bidimensionnel de l'émulsion (3), et une construction d'une image bidimensionnelle de l'émulsion (3) à partir dudit balayage. De préférence, les gouttes ne bougent pas pendant le balayage, par exemple en solidifiant la phase continue ou en utilisant un réseau bidimensionnel compact ou semi compact de gouttes. Le procédé selon l'invention peut comprendre en outre un suivi dans le temps d'une réaction chimique ou biologique se déroulant dans au moins une des gouttes. L'invention concerne aussi un dispositif mettant en oevre ce procédé. Application à la détection et/ou le tri de microgouttes jouant le rôle de microréacteurs ou contenant des cellules ou des molécules spécifiques, dans des domaines tels que l'expression de gènes ou le diagnostic.
Patent EP-2344562-A2 (EP)
Title: Compositions polymères fluorées et substrats traités
Inventor: BROWN GERALD ORONDE
IPC: C08G18/28
Filed: 2009-11-11
Abstract: La présente invention concerne une composition permettant de conférer des propriétés de surface à des substrats, laquelle composition comprend un polymère d'au moins un polyuréthane comportant au moins une liaison urée préparé (i) en faisant réagir (a) au moins un diisocyanate, un polyisocyanate, ou un mélange de ceux-ci, portant des groupes isocyanate, et (b) au moins un composé fluoré choisi parmi les composés de formule (I) : Rf1-L-X (I) dans laquelle Rf1 représente un radical alkyle monovalent linéaire ou ramifié partiellement ou totalement fluoré portant de 2 à 100 atomes de carbone, éventuellement interrompu par 1 à 50 atomes d'oxygène, le rapport entre atomes de carbone et atomes d'oxygène étant d’au moins 2 : 1, et aucun atome d'oxygène n'étant lié à un autre atome d'oxygène, L représente une liaison ou un groupe de liaison divalent linéaire ou ramifié portant de 1 à environ 20 atomes de carbone, ledit groupe de liaison étant éventuellement interrompu par 1 à environ 4 hétéroradicaux choisis dans le groupe constitué par -O-, -NR1-, -S-, -SO-, -SO 2 - et -N(R1)C(O)-, R1 représentant un hydrogène ou un radical alkyle en C 1  à C 6 , et ledit groupe de liaison étant éventuellement substitué par CH 2 Cl, et X représente un radical réagissant avec les isocyanates choisi dans le groupe constitué par -OH, -N(R)H et -SH; puis (ii) en les faisant réagir avec (c) de l'eau et (d) de 0,05 à environ 2,0 % en poids, rapporté au poids sec total de la composition, d'un composant particulaire fluoré réagissant avec les isocyanates.
Patent EP-2265465-A2 (EP)
Title: Emblème éclairé en deux couleurs
Inventor: KWON YOUNG CHUL
IPC: G09F13/08
Filed: 2009-03-24
Abstract: L'invention concerne un emblème éclairé en deux couleurs, qui comprend une partie d'aspect métallique dotée d'une couche d'aspect métallique, d'une couche de substrat qui porte la couche d'aspect métallique et de plusieurs éléments d'éclairage. La couche d'aspect métallique et la couche de substrat transmettent la lumière provenant des éléments d'éclairage. Les éléments d'éclairage émettent une lumière sous un angle d'émission prédéterminé qui est de 120 degrés. La couche de substrat est constituée d'ABS semi-transparent. La couche de substrat comprend une surface extérieure qui porte la couche d'aspect métallique et une surface intérieure qui est tournée vers les éléments d'éclairage et dont la structure rugueuse amène une diffusion de la lumière. La distance entre la surface intérieure de la couche de substrat et les éléments d'éclairage est comprise dans la plage de 7 à 10 mm. L'élément d'éclairage comprend une LED et un élément de guidage de lumière qui guide la lumière émise par le LED à travers et à l'intérieur de l'angle prédéterminé.
Patent EP-2317881-A2 (EP)
Inventor: CECCHETTO ANDREA
IPC: A24D1/02
Filed: 2009-06-02
Abstract: L'invention porte sur un article à fumer (1), comprenant un bâton de tabac (2), un filtre (4) situé à l'extrémité côté bouche de l'article à fumer (1), au moins un matériau d’embout (6), pour fixer le filtre (4) au bâton de tabac (2), le ou les matériaux d’embout (6) comprenant au moins une section transparente (7), l'article à fumer (1) comprenant de plus une zone de ventilation (8) en amont de la ou des sections transparentes (7). L'invention porte de plus sur un matériau d’embout (6) pour un tel article à fumer (1). (Fig. 1)
Patent EP-2292013-A2 (EP)
Inventor: DE NIJS GILEIN
IPC: H04N7/56
Filed: 2009-06-04
Abstract: There is provided a method for synchronizing a plurality of components of a broadcast media stream, the method comprising buffering (18) streams of data samples for a plurality of components of a broadcast media stream and buffering a plurality of information packets, the stream of data samples for each of the plurality of components including relative timing information, each information packet comprising timing information indicating a relationship between the relative timing information in the components and an absolute time; performing (16) a look-ahead action on the buffered information packets to extract timing information for each of the plurality of components; and using (16) the extracted timing information and relative timing information to synchronize the plurality of components.
Patent EP-2310061-A2 (EP)
Title: Matériau de matrice extracellulaire isolé comprenant un fascia sous-séreux
Inventor: SHAH BHAVIN
IPC: A61L27/50
Filed: 2009-06-29
Abstract: La présente invention concerne des matériaux de matrice extracellulaire purifiée isolés à partir de la paroi abdominale d’animaux et comprenant la couche de fascia sous-séreux de la paroi abdominale. De tels matériaux médicaux peuvent avoir une utilité dans le traitement de tissu endommagé et dans certains aspects dans la production de support de tissu pour la réparation d’hernies. La présente invention concerne en outre des procédés de fabrication et d’utilisation.
Patent EP-2329204-A2 (EP)
Title: Soupape d'expansion avec égalisation de force
Inventor: PAWLIK JENS
IPC: F16B39/04
Filed: 2009-09-03
Abstract: L’invention porte sur une soupape d’expansion (1) comprenant un orifice d’admission (2), au moins un orifice de sortie (3) ainsi qu’une première et une seconde parties de soupape. L’orifice d’entrée est conçu pour recevoir un milieu fluide dans un état liquide. Le(s) orifice(s) de sortie est/sont conçu(s) pour amener ledit milieu fluide dans un état partiellement gazeux jusqu’à un chemin d’écoulement. Les parties de soupape sont agencées mobiles les unes par rapport aux autres de telle façon que les positions mutuelles de la première partie de soupape et de la seconde partie de soupape déterminent un écoulement de fluide entre l’orifice d’entrée (2) et le(s) orifice(s) de sortie (3). En fonctionnement normal, une force résultante agit sur la première partie de soupape et/ou sur la seconde partie de soupape pour presser lesdites première et seconde parties de soupape l’une vers l’autre. La soupape d’expansion (1) comprend des moyens servant à réduire la force résultante agissant sur la (les) partie(s) de soupape. Les parties de soupape peuvent ainsi être facilement déplacées l’une par rapport à l’autre, et la force nécessaire au fonctionnement de la soupape (1) est ainsi réduite.
Patent EP-2300035-A2 (EP)
Inventor: DIMARCHI RICHARD D
IPC: C07K14/605
Filed: 2009-06-16
Abstract: Glucagon peptides that exhibit GIP agonist activity in addition to glucagon and/or GLP-I activity are provided. Pharmaceutical compositions comprising such glucagon peptides and therapeutic methods of using such peptides are also provided.
Patent EP-2381821-A2 (EP)
Inventor: CHAMEROY ERIC
IPC: A47J27/09
Filed: 2009-12-16
Abstract: The invention relates to a food pressure cooker device, comprising a chamber, a lid, a first element (6) permitting a user to control the locking/unlocking of the lid relative to the chamber and a second element (9), permitting a user to alter the pressure in the device, said first and second elements (6, 9) being mobile relative to each other, characterised in that the first and second elements (6, 9) interact with each other such that the relative mobility thereof depends at least partly on the relative position thereof. Food pressure cooking devices.
Patent EP-2316249-A2 (EP)
Inventor: QI EMILY
IPC: H04W48/16
Filed: 2009-08-06
Abstract: An embodiment of the present invention provides a method of dynamically handing over master functionality from a wireless station configured as a master station to another peer station in a wireless network, comprising, discovering the peer station's Master/AP capability, which may be, but is not required to be, via a (Re)Association request, selecting the peer station to be a new master station based on predetermined parameters, passing the basic service set (BSS) context from the master station to the new master station in a master station Role Request message before transitioning, notifying the new master station to activate its master station role via the master station Role Request message, and switching by the client station to the role of new master station upon receipt of an AP Role Activation message and starting to send Beacons with a BSSID that is the same as used in Beacons of the previous master station.
Patent EP-2308072-A2 (EP)
Inventor: SULLIVAN NEAL T
IPC: H01J43/24
Filed: 2009-06-19
Abstract: L'invention concerne une plaque de microcanaux comprenant un substrat percé de microcanaux s'étendant de sa surface supérieure à sa surface inférieure. Une couche résistive formée sur la surface extérieure des canaux assure une conduction ohmique d'une résistivité prédéterminée sensiblement constante. Une couche émettrice est formée sur la couche résistive, une électrode supérieure est placée sur la surface supérieure du substrat et une électrode inférieure est placée sur la surface inférieure du substrat.
Patent EP-2376702-A2 (EP)
Title: Sèche-linge doté d'un dispositif d'évacuation de corps étrangers
Inventor: AHN SEUNG-PHYO
IPC: D06F58/22
Filed: 2009-12-16
Abstract: L'invention concerne un dispositif d'évacuation de corps étrangers pour un sèche-linge. Dans un mode de réalisation, ce dispositif d'évacuation de corps étrangers pour sèche-linge comporte un boîtier doté d'un orifice d'entrée d'air dans lequel pénètre de l'air évacué par le tambour, un orifice d'évacuation d'air et un orifice d'évacuation de corps étrangers; une unité filtrante disposée dans le boîtier et pourvue d'un filtre; et une unité de nettoyage qui se déplace relativement au filtre et qui comporte un ou plusieurs dispositifs de nettoyage pour évacuer les corps étrangers accumulés dans le filtre.
Patent EP-2224195-A2 (EP)
Inventor: SONODA YASUAKI
IPC: F25D29/00
Filed: 2010-02-19
Abstract: A centralized-monitoring apparatus (10), which centralized monitors a device including a storage (2), a temperature sensor (25) to detect a temperature therein, and a temperature-variable device to cool or heat inside the storage such that the temperature reaches a set object-preservation temperature, comprises: an input device (16, 17) to be input with first information indicative of a time zone in which the temperature-variable device performing power-saving operation and second information indicative of a set temperature of the time zone; a storage device (14) to store the first-and-second information from the input device; a timing device (12) to measure a current time; and a control device (11) to control the temperature-variable device, based on the first-and-second information and current time, so as to start operation of turning the temperature to the set temperature when the current time reaches a starting time of the time zone, and terminate the operation when the current time reaches an ending time thereof.
Patent EP-2224462-A2 (EP)
Inventor: OMORI KAZUHIRO
IPC: C22C1/04
Filed: 2001-08-09
Abstract: A niobium powder comprising at least one element selected from the group consisting of rubidium, cesium, strontium, barium, scandium, yttrium, lanthanum, praseodymium, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium, hafnium, vanadium, osmium, iridium, platinum, gold, cadmium, mercury and lead; a sintered body of the niobium powder; a capacitor comprising a sintered body as one electrode, a dielectric material formed on the surface of the sintered body, and counter electrode provided on the dielectric material; an electronic circuit using said capacitor and an electronic instrument using said capacitor.
Patent EP-2243383-A2 (EP)
Inventor: HAYES KENNETH C
IPC: A23L33/00
Filed: 2006-04-04
Abstract: Disclosed is a method and composition for nutritionally improving glucose and insulin balance in an individual. The invention further provides a method for treating a comorbidity of diabetes. In one embodiment, the invention provides a nutritional formulation comprising: a protein source; a fat source; and a carbohydrate source, wherein the protein source, the fat source, and the carbohydrate source are in a ratio of about 1:1:1, each comprising about one third of the total calories of the composition.
Patent EP-2311862-A2 (EP)
Inventor: SAHIN UGUR
IPC: C12N15/113
Filed: 2003-03-12
Abstract: A pharmaceutical composition containing an agent (A) that: (a) inhibits expression or activity of a tumor-associated antigen (TAg); (b) has selective tumor-inhibiting activity against cells with (abnormal) expression of TAg; or (c) increases the amount of complex formed between an HLA (human leukocyte antigen) molecule and TAg, or its fragment, is new. A pharmaceutical composition containing an agent (A) that: (a) inhibits expression or activity of a tumor-associated antigen (TAg); (b) has selective tumor-inhibiting activity against cells with (abnormal) expression of TAg; or (c) increases the amount of complex formed between an HLA (human leukocyte antigen) molecule and TAg, or its fragment. TAg is encoded by nucleic acid (NA) that: (a) comprises any of 28 defined sequences given in the specification, or their fragments; (b) can hybridize to (a) under stringent conditions; (c) is a degenerate version of (a) or (b); or (d) is complementary to (a)-(c). Independent claims are also included for: (1) a pharmaceutical composition containing one or more of TAg, NA encoding TAg, antibody that binds to TAg, antisense sequences specific for NA, host cells that express TAg, or isolated complex of TAg with an HLA molecule (TAg may always by a fragment); (2) diagnosing diseases associated with (abnormal) expression of TAg (M1); (3) determining regression, progression or outbreak of diseases associated with (abnormal) expression of TAg (M2); (4) treating diseases associated with (abnormal) expression of TAg (M3); (5) NA as new compounds; (6) a nucleic acid (NA1) that encodes any of 35 specified peptide sequences or their fragments; (7) a recombinant DNA or RNA (NA2) that includes NA or NA1; (8) a host cell containing NA, NA1 or NA2; (9) proteins encoded by NA1 and their fragments that are immunogenic or can bind to HLA receptors or human antibodies; (10) agents (B) that bind specifically to a protein encoded by NA; (11) antibodies (Ab) that bind specifically to a complex of: (a) protein or its fragments encoded by NA; and (b) Major Histocompatibility (MHC) molecules to which (a) bind, but does not bind to (i) or (ii) singly; (12) a conjugate (C) between (B) or Ab and a diagnostic or therapeutic agent; (13) a kit for detecting (abnormal) expression of TAg; (14) recombinant DNA that includes a promoter region derived from NA; and (15) treatment, diagnosis and monitoring of metastatic cancer associated with (abnormal) expression of TPTE. ACTIVITY : Cytostatic. No biological data given. MECHANISM OF ACTION : Vaccine; Antisense/antibody inhibition of gene expression or activity.
Patent EP-2172852-A2 (EP)
Inventor: MENDEZ DANIEL
IPC: G06F21/62
Filed: 1998-07-23
Abstract: A client stores a first set of workspace data, and is coupled via a computer network to a global server. The client may be configured to synchronize portions of the first set of workspace data with the global server, which stores independently modifiable copies of the portions. 
     The global server may also store workspace data which is not downloaded from the client, and thus stores a second set of workspace data. The global server may be configured to identify and authenticate a user seeking global server access from a remote terminal, and is configured to provide access to the first set or to the second set. Further, services may be stored anywhere in the computer network. The global server may be configured to provide the user with access to the services. The system may further include a synchronization-start module at the client site (which may be protected by a firewall) that initiates interconnection and synchronization with the global server when predetermined criteria have been satisfied.
Patent EP-2287692-A2 (EP)
Inventor: YAMADA HIROAKI
IPC: H04L12/28
Filed: 2010-02-18
Abstract: This invention enables an abnormality analysis to be easily and reliably performed in the FA system of the EtherCAT (registered trademark). A controller has a protocol monitor function of operating in a monitor system program, and constantly monitors data communicated with a remote device. The controller has an abnormality diagnosis function of detecting abnormality, and thus holds the data monitored immediately before when abnormality is detected. As the protocol monitor function is incorporated, a protocol monitor does not need to be newly plugged into the network as an external device after the occurrence of abnormality, and the data that becomes the cause can be held from the abnormality that occurred first by monitoring from the beginning of the operation of the system and can be used for analysis.
Patent EP-2221800-A2 (EP)
Inventor: SAMPSELL JEFFREY BRIAN
IPC: G09G3/34
Filed: 2004-11-22
Abstract: A light modulator is arranged as an array of rows and columns of interferometric display elements. Each element is divided into sub-rows of sub-elements. Array connection lines transmit operating signals to the display elements, with one connection line corresponding to one row of display elements in the array. Sub-array connection lines electrically connect to each array connection line. Switches transmit the operating signals from each array connection line to the sub-rows to effect gray scale modulation.
Patent EP-2280246-A2 (EP)
Inventor: SARUKI SHUNJI
IPC: G01D5/14
Filed: 2010-07-07
Abstract: The angle-of-rotation sensor apparatus of the invention comprises a shaft (10) supported rotatably about an axial center, a permanent magnet (20) fixed to one end face of the shaft, and a magnetic field sensor device (30) located in opposition to the permanent magnet at a constant spacing. The permanent magnet used is in a cuboidal shape and magnetized in the minor axis (X) direction at the rectangular surface opposing to the magnetic field sensor device. The minor axis side is defined as the X direction and the major axis side as the Y direction. Given the opposing surface of the same area, the area where the angle distribution of the magnetic field emitted out of the permanent magnet can be placed in a uniform direction is made so wide that the tolerance range for axial alignment errors between the magnetic field sensor device and the permanent magnet can be enlarged.
Patent EP-2287009-A2 (EP)
Inventor: BREWINGTON GRACE T
IPC: B41M7/00
Filed: 2010-08-10
Abstract: An erasable media imaging device includes an input for supplying erasable media to the imaging device, the erasable media being one of an imaged erasable medium and a non-imaged erasable medium. An erase subsystem is provided for erasing an imaged erasable medium and a write subsystem is provided for imaging a non-imaged erasable medium, the erase subsystem and function decoupled from the write subsystem and function. In a corresponding method, one of an imaged erasable medium and a non-imaged erasable medium are supplied to the imaging device. The method further includes selecting only one of an erase mode and a write mode, the erase mode decoupled from the write mode, erasing an imaged erasable medium in the erase mode, and imaging the non-imaged erasable medium in the write mode.
Patent EP-2290545-A2 (EP)
Inventor: ANDREOLI JEAN-MARC
IPC: G06F11/34
Filed: 2010-08-18
Abstract: In a monitoring method, a time sequence of information pertaining to a monitored device, network, or system is recorded, comprising observations of the monitored device, network, or system and known prior correct action recommendations for the monitored device, network, or system. A hidden Markov model (HMM) operating on the time sequence of information is maintained. The HMM comprises a hidden state (50) of the monitored device, network, or system. A current state of the monitored device, network, or system is classified (52) using a classification value comprising an emission of the HMM that depends on an estimate of the distribution of the hidden state and on a selected portion of the time sequence of information. An action recommendation is generated (54) for the current state of the monitored device, network, or system based on the classification value.
Patent EP-2293660-A2 (EP)
Inventor: YAMAOKA NOBUYOSHI
IPC: G01K1/02
Filed: 2010-08-31
Abstract: A temperature predicting apparatus for predicting possible abnormal temperature of air for cooling at least one of electronic devices mounted on a rack, the temperature predicting apparatus includes a storing section for storing temperature information related to at least one temperature measured by a temperature sensor provided on an intake side of the electronic device, and a controller for estimating a change tendency in the temperature on the intake side of the electronic device on the basis of the temperature information stored in the storing section, and predicting the possible abnormal temperature on the basis of the estimated change tendency.
Patent EP-2258845-A2 (EP)
Inventor: NARGESSI R D
IPC: C12Q1/68
Filed: 2002-09-12
Abstract: The invention relates to a method for the isolation and purification of nucleic acids such as DNA, RNA, and PNA from various sources using cellulose particles or cellulose paper. Adjusting the concentrations of the salt and polyalkylene glycol to the levels that result in binding of nucleic acids to the cellulose particles or cellulose paper. Separating the nucleic acids bound to the cellulose particles or paper and eluting the nucleic acids from the particles or paper.
Patent EP-2311593-A2 (EP)
Inventor: LUO YUEFENG
IPC: B23H9/10
Filed: 2010-09-27
Abstract: A method of electrochemical machining that includes the steps of: positioning a workpiece (106) and a tooling piece (104) in a first position; moving at least one of the workpiece (106) and the tooling piece (104) toward the other such that the workpiece (106) and the tooling piece (104) occupy a second position; moving at least one of the workpiece (106) and the tooling piece (104) away from the other such that the workpiece (106) and the tooling piece (104) occupy a third position; and during at least a portion of the moving of the workpiece (106) and/or the tooling piece (104) from the first position to the second position and from the second position to the third position, using a power supply to apply a voltage across a gap formed between the workpiece (106) and the tooling piece (104).